Jefferies Downgrades AcelRx Pharmaceuticals After FDA Requests Additional Clinical Trial For Lead Drug Zalviso

By: via Benzinga
Shares of AcelRx Pharmaceuticals Inc (NASDAQ: ACRX) were down substantially on Tuesday after its earnings call on Monday. Although ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.